Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

A new US study shows that people who are less physically active are more likely to be hospitalised and die with COVID-19. According to these new calculations, being inactive puts you at a greater risk from COVID-19 than any other risk factor except age and having had an organ transplant. If this is right, it’s a big deal.

In the study, healthcare providers asked people about how much they exercised over a two-year period prior to the pandemic. Using this information, people were categorised into three groups. The first group – described as “consistently inactive” – exercised for no more than 10 minutes per week. The second group engaged in “some activity” – exercising for between 11 minutes and 149 minutes a week. The third group consistently met physical activity guidelines, exercising for 150 minutes a week or more. Exercise was defined as moderate to strenuous activity, an example being a “brisk walk”.

Compared to people who were exercising for at least 150 minutes a week, people who were consistently inactive were over twice as likely to be hospitalised and to die due to COVID-19. They also had a greater risk of hospitalisation and death than people doing some physical activity.

Read the full article on The Conversation website, written by Jamie Hartmann-Boyce (Nuffield Department of Primary Care Health Sciences).

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

Daily contact COVID-19 testing for students effective at controlling transmission in schools

A study by the University of Oxford has found that daily testing of secondary school students who were in contact with someone with COVID-19 was just as effective in controlling school transmission as the current 10-day contact isolation policy.